Literature DB >> 20352162

4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries.

Werner Koch1, Matthias Schrempf, Anna Erl, Jakob C Mueller, Petra Hoppmann, Albert Schömig, Adnan Kastrati.   

Abstract

We assessed the association between common variation at the SERPINE1 (PAI1) locus and myocardial infarction (MI). Haplotype-tagging polymorphisms, including the 4G/5G deletion/insertion polymorphism and seven single nucleotide polymorphisms, were analysed in a German sample containing 3,657 cases with MI and 1,211 controls. The association between the 4G/5G polymorphism and MI was examined in a meta-analysis of data extracted from 32 studies (13,267 cases/14,716 controls). In addition, the relation between the 4G/5G polymorphism and coronary diseases, comprising MI, coronary artery disease, coronary heart disease, or the acute coronary syndrome, was assessed in a combined analysis enclosing 43 studies (17,278 cases/18,039 controls). None of the tagging polymorphisms was associated with MI in the present sample (p <or= 0.34). The adjusted odds ratio (OR) for 4G allele carriers was 1.02 (95% confidence interval [CI] 0.87-1.19) compared to the 5G5G genotype. None of 13 common (frequency >1.0%) 8-marker haplotypes was related to the risk of MI. In a meta-analysis specifically addressing the association with MI, no elevated risk was found in the carriers of the 4G allele (OR 1.07, 95% CI 0.99-1.16; p = 0.11). A more general combined analysis of coronary diseases showed a marginally increased risk in 4G allele carriers (OR 1.08, 95% CI 1.00-1.16; p = 0.044). In essence, tagging polymorphisms, including the 4G/5G polymorphism, and common haplotypes of the SERPINE1 gene region were not associated with MI in a German sample, and no compelling evidence was obtained for a relationship of the 4G/5G polymorphism to MI and coronary atherosclerosis in a meta-analysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352162     DOI: 10.1160/TH09-10-0702

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis.

Authors:  Zhongshu Liang; Weihong Jiang; Mao Ouyang; Kan Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Genetic Insights into Cerebrovascular Disorders: A Comprehensive Review.

Authors:  Fawaz Al-Mufti; Ahmed Alkanaq; Krishna Amuluru; Rolla Nuoman; Ahmed Abdulrazzaq; Tamarah Sami; Halla Nuoaman; Caroline Hayes-Rosen; Charles J Prestigiacomo; Chirag D Gandhi
Journal:  J Vasc Interv Neurol       Date:  2017-10

3.  Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection.

Authors:  Outi Laine; Lotta Joutsi-Korhonen; Satu Mäkelä; Jussi Mikkelsson; Tanja Pessi; Sari Tuomisto; Heini Huhtala; Daniel Libraty; Antti Vaheri; Pekka Karhunen; Jukka Mustonen
Journal:  Thromb Res       Date:  2011-11-30       Impact factor: 3.944

Review 4.  PAI-1 in tissue fibrosis.

Authors:  Asish K Ghosh; Douglas E Vaughan
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

5.  Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis.

Authors:  Huifeng Zhang; Pingshuan Dong; Xuming Yang; Zhenghao Liu
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 6.  Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis.

Authors:  Samira Tabaei; Melodi Omraninava; Sahar Mehranfar; Morteza Motallebnezhad; Seyedeh Samaneh Tabaee
Journal:  Biochem Genet       Date:  2022-01-18       Impact factor: 2.220

7.  Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation.

Authors:  Jie Huang; Maria Sabater-Lleal; Folkert W Asselbergs; David Tregouet; So-Youn Shin; Jingzhong Ding; Jens Baumert; Tiphaine Oudot-Mellakh; Lasse Folkersen; Andrew D Johnson; Nicholas L Smith; Scott M Williams; Mohammad A Ikram; Marcus E Kleber; Diane M Becker; Vinh Truong; Josyf C Mychaleckyj; Weihong Tang; Qiong Yang; Bengt Sennblad; Jason H Moore; Frances M K Williams; Abbas Dehghan; Günther Silbernagel; Elisabeth M C Schrijvers; Shelly Smith; Mahir Karakas; Geoffrey H Tofler; Angela Silveira; Gerjan J Navis; Kurt Lohman; Ming-Huei Chen; Annette Peters; Anuj Goel; Jemma C Hopewell; John C Chambers; Danish Saleheen; Per Lundmark; Bruce M Psaty; Rona J Strawbridge; Bernhard O Boehm; Angela M Carter; Christa Meisinger; John F Peden; Joshua C Bis; Barbara McKnight; John Öhrvik; Kent Taylor; Maria Grazia Franzosi; Udo Seedorf; Rory Collins; Anders Franco-Cereceda; Ann-Christine Syvänen; Alison H Goodall; Lisa R Yanek; Mary Cushman; Martina Müller-Nurasyid; Aaron R Folsom; Saonli Basu; Nena Matijevic; Wiek H van Gilst; Jaspal S Kooner; Albert Hofman; John Danesh; Robert Clarke; James B Meigs; Sekar Kathiresan; Muredach P Reilly; Norman Klopp; Tamara B Harris; Bernhard R Winkelmann; Peter J Grant; Hans L Hillege; Hugh Watkins; Timothy D Spector; Lewis C Becker; Russell P Tracy; Winfried März; Andre G Uitterlinden; Per Eriksson; Francois Cambien; Pierre-Emmanuel Morange; Wolfgang Koenig; Nicole Soranzo; Pim van der Harst; Yongmei Liu; Christopher J O'Donnell; Anders Hamsten
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

8.  Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis.

Authors:  Vijayakrishna Kolur; Basavaraj Vastrad; Chanabasayya Vastrad; Shivakumar Kotturshetti; Anandkumar Tengli
Journal:  BMC Cardiovasc Disord       Date:  2021-07-04       Impact factor: 2.298

9.  Genetics of cerebral vasospasm.

Authors:  Travis R Ladner; Scott L Zuckerman; J Mocco
Journal:  Neurol Res Int       Date:  2013-04-11

10.  Etiopathogenesis of Sheehan's Syndrome: Roles of Coagulation Factors and TNF-Alpha.

Authors:  Halit Diri; Elif Funda Sener; Fahri Bayram; Nazife Tascioglu; Yasin Simsek; Munis Dundar
Journal:  Int J Endocrinol       Date:  2014-04-10       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.